National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 6/11/2021 release of VAERS data:

Found 332 cases where Vaccine is COVID19 and Symptom is Guillain-Barre syndrome



Case Details

This is page 13 out of 34

Result pages: prev   4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22   next


VAERS ID: 1199613 (history)  
Form: Version 2.0  
Age: 50.0  
Sex: Male  
Location: Colorado  
Vaccinated:2021-04-01
Onset:2021-04-02
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 AR / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Asthenia, CSF glucose increased, CSF protein increased, CSF red blood cell count positive, Coordination abnormal, Fall, Gait disturbance, Guillain-Barre syndrome, HIV test, Herpes simplex test negative, Hypoaesthesia, Immunoglobulin therapy, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal abnormal, Muscle spasms, Myelitis transverse, Neck pain, Paraesthesia, Urinary retention, Vitamin B12
SMQs:, Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Arthritis (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Diovan po, testosterone IM, metaxalone po
Current Illness: N/A
Preexisting Conditions: Hypertension, chronic back pain, exercise-induced asthma, OSA, hormone replacement therapy
Allergies: NKDA
Diagnostic Lab Data: 4/8-4/11: HSV (CSF) -, LP 3 RBC, 1 WBC, glucose 104, protein 129; Vit B12 = 288, HIV- 4/7: MRI lumbar spine: mild to moderate left and mild right neural foraminal stenosis. Mild
CDC Split Type:

Write-up: Received Moderna COVID vaccination 4/1/21. About 27 hours later, he felt muscle spasming across his chest. He then developed neck pain, tingling that goes into right and left arms/fingers. Was started on oral steroids by his PCP on 4/6/21. Given worsening symptoms and new development of urinary retention. Patient was admitted to Hospital 4/8-4/11. Suspected to have cervical transverse myelitis. Re-admitted 4/12 due to worsening generalized weakness, significant numbness, gait/coordination issues, and several falls. Differential diagnosis includes guillain barre syndrome vs. transverse myelitis. No MS on brain MRI. No cord lesion. Treatment included IVIG 0.5g/kg daily x 4 days, B12, 1 mg IM daily x 3 days. bilateral neural foraminal stenosis at L5-S1. 4/7: MRI cervical spine: Small focal area of increased T2 signal within the central cervical cord at the C2 level without associated postcontrast enhancement. A demyelinating disease is leading differential consideration. 4/11: MRI brain: normal, no de-myelinating disease; MRI C-spine: severe cervical stenosis with flattening of spinal cord but no cord edema/enhancement.


VAERS ID: 1201507 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Unknown  
Location: Texas  
Vaccinated:2021-03-01
Onset:2021-03-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Dizziness, Gait inability, Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dystonia (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Vestibular disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Very dizzy after the second injection and now she can not walk. Symptoms of Guillain Barre Syndrome.


VAERS ID: 1202805 (history)  
Form: Version 2.0  
Age: 29.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-01-09
Onset:2021-03-27
   Days after vaccination:77
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Autonomic nervous system imbalance, Demyelinating polyneuropathy, Electromyogram abnormal, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Paraesthesia, Respiratory disorder, Scan with contrast abnormal
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Acute central respiratory depression (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Respiratory failure (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Eslicarbazapine 800mg nightly folic acid 1mg daily
Current Illness: None
Preexisting Conditions: Epilepsy
Allergies: Lamictal - rash Vimpat - rash sulfa drugs- rash
Diagnostic Lab Data: On 3/31/2021 MRI brain, C-spine, T-spine, L-spine w/wo contrast (showed enhancement of nerve roots) On 47/2021: EMG This study is consistent with the diagnosis of Guillain-Barr? with evidence of a demyelinating polyneuropathy
CDC Split Type:

Write-up: Guillian-Barre Syndrome/Acute inflammatory demyelinating polyradiculoneuropathy - ascending paralysis and paresthesias along with autonomic symptoms. Refractory to IVIG. Patient was sent home after course but then continued to worsen and couldn''t ambulate . She was readmitted and started on plasmapheresis and pulsed steroids. Respiratory function has been relatively spared, but she has not clearly yet obtained her nadir.


VAERS ID: 1203851 (history)  
Form: Version 2.0  
Age: 78.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-03-01
Onset:2021-03-03
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 043620A / UNK LA / IM
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 043L20A / UNK LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Anti-ganglioside antibody negative, Antiacetylcholine receptor antibody, Ataxia, Computerised tomogram normal, Computerised tomogram spine, Dysphagia, Dysphonia, Electromyogram abnormal, Fall, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Magnetic resonance imaging head normal, Magnetic resonance imaging neck, Magnetic resonance imaging spinal normal, Muscular weakness, Nerve conduction studies abnormal, Neurological examination, Scan with contrast normal
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tylenol 250mg BID PRN (3 times/week), Vitamin C & D
Current Illness: Mild Residual weakness from right sided Stroke x 15 years
Preexisting Conditions: Hypertension x 15 years, CVA 15 yrs ago, High Cholesterol, COPD, Lumbar degenerative disc disease
Allergies: Latex-Rash, Nifedipine-Bilateral Leg and Calf pain
Diagnostic Lab Data: EMG/NCS 03/15/2021 consistent with acute inflammatory demyelinating polyradiculoneuropathy form of Guillain-Barre syndrome. CT cervical spine without contrast 03/08 and 03/15 normal
CDC Split Type:

Write-up: Patient received 2nd dose of vaccination on 03/01/2021 and developed symptoms on 03/03/2021. He presented with bilateral numbness in feet ascending to his mid shins and weakness complicated with multiple falls due to severe ataxia. He did not report any head injury or loss of consciousness. He also reported mild dysphagia, changes in voice and left arm weakness. Neurological examination showed bilateral leg strength 4/5 and numbness. The patient was admitted to hospital and given IVIG for 7 days before transfer to an acute inpatient rehab facility. The patient was discharged from rehab facility on 04/05/2021 and still has some residual weakness and numbness.


VAERS ID: 1203883 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Kansas  
Vaccinated:2021-03-16
Onset:2021-04-08
   Days after vaccination:23
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 014M20A / 1 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Asthenia, Diarrhoea, Diplegia, Endotracheal intubation, Facial paralysis, Gait disturbance, Guillain-Barre syndrome, Hypoaesthesia, Mechanical ventilation, Mobility decreased, Musculoskeletal disorder, Plasmapheresis
SMQs:, Rhabdomyolysis/myopathy (broad), Angioedema (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hearing impairment (broad), Noninfectious diarrhoea (narrow), Respiratory failure (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: Diarrhea episode 3/31/21
Preexisting Conditions: HTN, HLD, asthma, carpal tunnel, obesity
Allergies: none
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient presented to local ED on 4/8 after having symptoms ~0400 with right sided numbness unable to move fingers on right hand. Patient also unable to use right leg properly to walk. Later ~0800 weakness, numbness progressed to left side and patient had worsening paralysis to all extremities, trunk, and to face. Patient was transferred to our facility for concern for guillain-barre syndrome. Once admitted, patient was intubated for airway protection and remains on ventilator receiving plasma exchange sessions for presumed diagnosis.


VAERS ID: 1204072 (history)  
Form: Version 2.0  
Age: 24.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-03-04
Onset:2021-04-05
   Days after vaccination:32
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805031 / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Anaesthesia oral, Antinuclear antibody positive, Balance disorder, Blood albumin increased, CSF protein increased, Condition aggravated, Dry mouth, Gait disturbance, Guillain-Barre syndrome, Headache, Hyperaesthesia, Hypoaesthesia, Immunoglobulin therapy, Injection site discomfort, Laboratory test abnormal, Limb discomfort, Lumbar puncture abnormal, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Malaise, Pruritus, Temperature intolerance
SMQs:, Anaphylactic reaction (broad), Peripheral neuropathy (narrow), Systemic lupus erythematosus (narrow), Anticholinergic syndrome (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Vestibular disorders (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Creatine, multivitamins
Current Illness: None
Preexisting Conditions: none
Allergies: None
Diagnostic Lab Data: MRI, multiple antibody studies that are positive for antinuclear antibodies n Her 2, positive to dilution 1:40 and 1:160 on 4/6 and 1:40 on 4/9, elevated CDG protein and albumin.
CDC Split Type:

Write-up: Patient had an initial response 2 days after the vaccine, with general malaise, dry mouth, headache and itching hands as well as local discomfort at the injection site that seemed to resolve spontaneously. On April 3rd he had non-specific changes in his hands that he attributed to cold weather that led to discomfort when running them under warm water. By monday APril 5th he was having worsening sensitivity in his hands and feet to heat, touch and experienced numbness. he also began to have difficulty walking. He went to the ER April 6th and was discharged April 7th after undergoing MRI of the brain and spinal cord, labs and lumbar puncture, with a presumptive diagnosis of early Guillain-barre Syndrome. His symptoms continued to worse, loss of gait was more pronounced as well as loss of balance and new off sensations in his tongue. He was admitted to the hospital, continued to undergo diagnostic workout. Results from tests on APril 6th came back positive for Anti nuclear antibodies and high protein in his CSF. He was treated with 3 days of infused Immunoglobolin therapy and was discharged on April 11th with a diagnosis of likely GBS. His symptoms continue to worsen slightly, but with less day to day decline


VAERS ID: 1204762 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-01-13
Onset:2021-02-10
   Days after vaccination:28
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 012L20A / 1 LA / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Neck pain, Pyrexia
SMQs:, Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Intervertebral disc operation (She had a surgical procedure done year and half ago where two artificial discs were put in her neck.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: They think she has Guillen barre; severe neck pain and pain on the side of neck; numbness across the shoulders and down the arms and leg numbness; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of GUILLAIN-BARRE SYNDROME (They think she has Guillen barre) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Intervertebral disc operation (She had a surgical procedure done year and half ago where two artificial discs were put in her neck.). On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced GUILLAIN-BARRE SYNDROME (They think she has Guillen barre) (seriousness criterion medically significant), NECK PAIN (severe neck pain and pain on the side of neck), HYPOAESTHESIA (numbness across the shoulders and down the arms and leg numbness) and PYREXIA (Low grade fever). At the time of the report, GUILLAIN-BARRE SYNDROME (They think she has Guillen barre), NECK PAIN (severe neck pain and pain on the side of neck), HYPOAESTHESIA (numbness across the shoulders and down the arms and leg numbness) and PYREXIA (Low grade fever) outcome was unknown. Concomitant product use was not provided. Treatment included prednisone for 15 days and cephalexin (500mg) for 7 days (both for unknown indication) and gabapentin (for neck pain). The patient is scheduled for cervical and brain MRI and also had cervical x-ray (results not reported). The patient opted not to have spinal tap. Based on the current available information which includes a temporal association between the use of the product and onset of the events, and excluding other etiologies, a causal relationship cannot be excluded. However the event of Guillen barre has not been confirmed. Additional information has been requested; Sender''s Comments: Based on the current available information which includes a temporal association between the use of the product and onset of the events, and excluding other etiologies, a causal relationship cannot be excluded. However the event of Guillen barre has not been confirmed. Additional information has been requested


VAERS ID: 1204923 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Female  
Location: Oregon  
Vaccinated:2021-03-12
Onset:2021-03-25
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1085018 / 1 UN / IM

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 19 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: apixaban (ELIQUIS) , cetirizine (ZYRTEC), digoxin, Ergocalciferol, Vitamin D2, furosemide, levothyroxine, potassium chloride (KLOR-CON M, VITAMIN B COMPLEX ORAL
Current Illness: heart failure, restrictive pericarditis
Preexisting Conditions: Hodgkins, BCL, afib, heart failure
Allergies: flecainide, amiodarone
Diagnostic Lab Data: Diagnosis of exclusion
CDC Split Type:

Write-up: Guillain-Barr? syndrome


VAERS ID: 1204953 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2021-03-15
Onset:2021-03-16
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1802070 / 1 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Axonal and demyelinating polyneuropathy, CSF test abnormal, Electromyogram abnormal, Guillain-Barre syndrome, Nerve conduction studies abnormal, Protein albumin ratio abnormal
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Combipatch, Buproprion, Tums, Adderall, Diazepam, Vitamin D, Folic acid, Sertraline, Trazodone
Current Illness: None
Preexisting Conditions: PTSD, dissociative disorder
Allergies: NSAIDs
Diagnostic Lab Data: CSF with cytoalbuminologic dissociation (protein of 242 and 7 nucleated cells). EMG/NCS consistent with acute inflammatory demyelinating and axonal polyneuropathy.
CDC Split Type:

Write-up: Patient was found to have Guillian-Barre Syndrome during admission beginning on 4/10/2021.


VAERS ID: 1205050 (history)  
Form: Version 2.0  
Age: 69.0  
Sex: Male  
Location: Oregon  
Vaccinated:2021-03-06
Onset:2021-03-27
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6199 / 1 LA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8732 / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: CSF culture negative, CSF glucose normal, CSF protein normal, CSF red blood cell count positive, CSF white blood cell count, Cervical spinal stenosis, Guillain-Barre syndrome, Magnetic resonance imaging neck, Magnetic resonance imaging thoracic, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Xarelto, Toprol XL
Current Illness: None
Preexisting Conditions: Atrial fibrillation status post ablation x3, mitral valve repair, hypertension
Allergies: None
Diagnostic Lab Data: CSF WBC count 2, RBC count 2, protein 38, glucose 55, Gram stain and culture negative. MRI cervical thoracic spine without contrast with moderate central canal stenosis at C5-C6
CDC Split Type:

Write-up: Patient developed ascending lower extremity weakness ultimately requiring hospitalization with clinical diagnosis of Guillain-Barre syndrome.


Result pages: prev   4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=13&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166